Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
Inv. presentation
|
|
Altimmune, Inc. (PIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 1.6% stake in EXIT FILING ALTIMMUNE INC |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 5.5% stake in Altimmune, Inc. |
| 02/14/2023 |
SC 13G/A
| Avidity Partners Management LP reports a 8.1% stake in Altimmune Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Asset Management, LP reports a 5.3% stake in Altimmune, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 12% stake in AMENDED FILING ALTIMMUNE INC |
| 04/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 1.6% stake in EXIT FILING ALTIMMUNE INC |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 4.2% stake in Altimmune, Inc. |
| 02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 4.8% stake in Altimmune, Inc. |
| 02/14/2022 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 3.1% stake in Altimmune, Inc. |
| 02/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 11.1% stake in AMENDED FILING ALTIMMUNE INC |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 3.1% stake in Altimmune, Inc. |
| 01/31/2020 |
SC 13G/A
| Hudson Bay Capital Management LP reports a 10% stake in Altimmune, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| OFCO Club V reports a 0.7% stake in Altimmune, Inc. |
| 02/08/2019 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 6% stake in Altimmune, Inc. |
| 02/05/2019 |
SC 13G/A
| Novartis Bioventures Ltd reports a 3.5% stake in Altimmune, Inc. |
| 02/01/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/04/2018 |
SC 13G/A
| Novartis Bioventures Ltd reports a 6.8% stake in Altimmune, Inc. |
| 02/14/2018 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 4% stake in ALTIMMUNE, INC. |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2018 |
SC 13G/A
| Truffle Capital S.A.S. reports a 10.3% stake in Altimmune, Inc. |
| 02/02/2018 |
SC 13G/A
| Novartis Bioventures Ltd reports a 18.4% stake in Altimmune, Inc. |
| 08/23/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| PHARMATHENE, INC reports a 4.8% stake in PHARMATHENE, INC. |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 10/05/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/18/2011 |
SC 13G/A
| PHARMATHENE, INC reports a 3.7% stake in PharmAthene, Inc. |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2009 |
SC 13G/A
| Steel Partners reports a 5% stake in PharmAthene, Inc. |
|
|